Cancers screening in an asymptomatic population by using multiple tumour markers

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Wang, Hsin Yao ^a   Hsieh, Chia Hsun ^b   Wen, Chiao Ni ^a   Wen, Ying Hao ^a   Chen, Chun Hsien ^c   Lu, Jang Jih ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; PROSTATE SPECIFIC ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; AFP PROTEIN, HUMAN; ANTIGEN CYFRA21.1; CYTOKERATIN 19; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASYMPTOMATIC DISEASE; BILE DUCT CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; K NEAREST NEIGHBOR; LIVER CANCER; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PREDICTIVE VALUE; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SKIN CANCER; STOMACH CANCER; SUPPORT VECTOR MACHINE; THYMUS CANCER; THYROID CANCER; URINARY TRACT CANCER; YOUDEN INDEX; AGED; BLOOD; EARLY CANCER DIAGNOSIS; MIDDLE AGED; NEOPLASMS; REGRESSION ANALYSIS; RISK MANAGEMENT; TAIWAN;

ADULT; AGED; ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KERATIN-19; MALE; MIDDLE AGED; NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK MANAGEMENT; SERPINS; SUPPORT VECTOR MACHINE; TAIWAN;

EID: 84977658343     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158285     Document Type: Article

References (30)

1. Tsao KC, Wu TL, Chang PY, Hong JH, Wu JT. Detection of carcinomas in an asymptomatic Chinese population: advantage of screening with multiple tumor markers. Journal of Clinical Laboratory Analysis. 2006; 20(2):42-6. PMID: 16538643
2. Wen YH, Chang PY, Hsu CM, Wang HY, Chiu CT, Lu JJ. Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience. Clinica chimica acta; international journal of clinical chemistry. 2015; 450:273-6. doi: 10.1016/j.cca.2015.09.004 PMID: 26344337
3. Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical & Paediatric Oncology. 2009; 30(1):1-8.
4. Duk JM, de Bruijn HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, et al. Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecologic oncology. 1990; 39(2):186-94. PMID: 2227594
5. Gupta D, Lis CG. Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature. Journal of Ovarian Research. 2009; 2:13. doi: 10.1186/1757-2215-2-13 PMID: 19818123
6. Wang H, Huang G. Application of support vector machine in cancer diagnosis. Medical oncology. 2011; 28 Suppl 1:S613-8. doi: 10.1007/s12032-010-9663-4 PMID: 20842538
7. Saito M, Aoki D, Susumu N, Suzuki A, Suzuki N, Udagawa Y, et al. Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society. 2005; 15(1):37-44.
8. Wild N, Andres H, Rollinger W, Krause F, Dilba P, Tacke M, et al. A combination of serum markers for the early detection of colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2010; 16(24):6111-21.
9. Cruz JA, Wishart DS. Applications of Machine Learning in Cancer Prediction and Prognosis. Cancer Informatics. 2006; 2:59-77.
10. Fan XJ, Wan XB, Huang Y, Cai HM, Fu XH, Yang ZL, et al. Epithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer. British journal of cancer. 2012; 106(11):1735-41. doi: 10.1038/bjc.2012.82 PMID: 22538975
11. Wan XB, Zhao Y, Fan XJ, Cai HM, Zhang Y, Chen MY, et al. Molecular prognostic prediction for locally advanced nasopharyngeal carcinoma by support vector machine integrated approach. PloS one. 2012; 7(3):e31989. doi: 10.1371/journal.pone.0031989 PMID: 22427815
12. Chawla N. Data Mining for Imbalanced Datasets: An Overview. In: Maimon O, Rokach L, editors. Data Mining and Knowledge Discovery Handbook: Springer US; 2005. p. 853-67.
13. Tang Y, Zhang YQ, Chawla NV. SVMs modeling for highly imbalanced classification. IEEE Transactions on Systems, Man, and Cybernetics, Part B: Cybernetics. 2009; 39(1):281-8.
14. Farquad MAH, Bose I. Preprocessing unbalanced data using support vector machine. Decision Support Systems. 2012; 53(1):226-33.
15. Chang CC, Lin CJ. LIBSVM: A library for support vector machines. ACM Trans Intell Syst Technol. 2011; 2(3):1-27.
16. Hsu CW, Chang CC, Lin CJ. A practical guide to support vector classification. Tech rep, Department of Computer Science, National Taiwan University. 2010.
17. Li DL, Shen F, Yin Y, Peng JX, Chen PY. Weighted Youden index and its two-independent-sample comparison based on weighted sensitivity and specificity. Chinese medical journal. 2013; 126 (6):1150-4. PMID: 23506596
18. Chen F, Xue Y, Tan MT, Chen P. Efficient statistical tests to compare Youden index: accounting for contingency correlation. Statistics in Medicine. 2015; 34(9):1560-76. doi: 10.1002/sim.6432 PMID: 25640747
19. Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health affairs (Project Hope). 2003; 22(3):61-76.
20. Verplancke T, Van Looy S, Benoit D, Vansteelandt S, Depuydt P, De Turck F, et al. Support vector machine versus logistic regression modeling for prediction of hospital mortality in critically ill patients with haematological malignancies. BMC medical informatics and decision making. 2008; 8:56. doi: 10.1186/1472-6947-8-56 PMID: 19061509
21. Becker N, Toedt G, Lichter P, Benner A. Elastic SCAD as a novel penalization method for SVM classification tasks in high-dimensional data. BMC bioinformatics. 2011; 12:138. doi: 10.1186/1471-2105-12-138 PMID: 21554689
22. Parry RM, Jones W, Stokes TH, Phan JH, Moffitt RA, Fang H, et al. k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. The pharmacogenomics journal. 2010; 10(4):292-309. doi: 10.1038/tpj.2010.56 PMID: 20676068
23. Kim SY, Moon SK, Jung DC, Hwang SI, Sung CK, Cho JY, et al. Pre-operative prediction of advanced prostatic cancer using clinical decision support systems: accuracy comparison between support vector machine and artificial neural network. Korean journal of radiology. 2011; 12(5):588-94. doi: 10.3348/kjr.2011.12.5.588 PMID: 21927560
24. Touitou Y, Darbois Y, Bogdan A, Auzéby A, Keusseoglou S. Tumour marker antigens during menses and pregnancy. British journal of cancer. 1989; 60(3):419-20. PMID: 2789952
25. Erbagci AB, Yilmaz N, Kutlar I. Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in healthy women. Disease markers. 1999; 15(4):259-67. PMID: 10689549
26. Abrão MS, Podgaec S, Pinotti JA, de Oliveira RM. Tumor markers in endometriosis. International Journal of Gynecology & Obstetrics. 1999; 66(1):19-22.
27. Gjavotchanoff R. CYFRA 21-1 in urine: a diagnostic marker for endometriosis? International journal of women's health. 2015; 7:205-11. doi: 10.2147/IJWH.S75288 PMID: 25709504
28. Parikh R, Mathai A, Parikh S, Chandra Sekhar G, Thomas R. Understanding and using sensitivity, specificity and predictive values. Indian Journal of Ophthalmology. 2008; 56(1):45-50. PMID: 18158403
29. González-Vélez H, Mier M, Julià-Sapé M, Arvanitis T, García-Gómez J, Robles M, et al. HealthAgents: distributed multi-agent brain tumor diagnosis and prognosis. Appl Intell. 2009; 30(3):191-202.
30. Koga Y, Yamazaki N, Takizawa S, Kawauchi J, Nomura O, Yamamoto S, et al. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening. Anticancer research. 2014; 34(1):169-76. PMID: 24403458